Brooks Laboratories Board to Consider Q2 FY27 Financial Results on 7th Nov'26
Brooks Laboratories Ltd 路 Others (Uncategorized) 路 03 Nov 2026, 5:34 pm
Brooks Laboratories Board to Consider Q2 FY27 Financial Results on 7th Nov'26 Brooks Laboratories Limited announced that its Board of Directors will meet on 7th Nov'26 to consider and approve the unaudited standalone and consolidated financial results, along with the Limited Review Report, for the quarter and half-year ended 30th Sep'26. Additionally, the insider trading window, closed since 1st Oct'26, will reopen 48 hours following the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Brooks Laboratories Ltd
- Intimation of upgrade in Credit Rating 路 12 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 路 07 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 路 07 Nov 2026
- Brooks Laboratories Limited has submitted to the Exchange, the financial results for the quarter and half year ended September 30, 2026. 路 07 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 路 07 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 07 Nov 2026
- Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve the Unaudited Standalone .... 路 07 Nov 2026
- BROOKS LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 07 Nov 2026
